503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Analyze DCF forecasts for the company and compare them with competitors.
198.27B
Better than BB's revenue of 718.00M.
17.96%
Better than BB's revenue growth rate of -19.60%.
100.24B
Better than BB's ebitda of -38.00M.
50.56%
Better than BB's ebitda margin of -5.29%.
85.78B
Better than BB's ebit of -211.95M.
43.26%
Better than BB's ebit margin of -29.52%.
14.46B
Worse than BB's depreciation of 173.95M.
104.75B
Better than BB's total cash of 712.00M.
52.83%
Worse than BB's cash as percentage of revenue of 99.16%.
44.26B
Worse than BB's receivables of 172.00M.
22.32%
Better than BB's receivables as percentage of revenue of 23.96%.
3.74B
Worse than BB's inventories of 0.00.
1.89%
Worse than BB's inventories as percentage of revenue of 0.00%.
19.00B
Worse than BB's accounts payable of 22.00M.
9.58%
Worse than BB's payables as percentage of revenue of 3.06%.
-23.89B
Better than BB's capital expenditure of -39.00M.
-12.05%
Better than BB's capex as percentage of revenue of -5.43%.
8.39%
Better than BB's weighted average cost of capital (wacc) of 8.61%.
8.53%
Better than BB's cost of equity of 9.44%.
4.26%
Better than BB's cost of debt of 4.40%.
0.90
Better than BB's beta of 1.07.
7.47B
Worse than BB's diluted shares outstanding of 584.54M.
97.85B
Worse than BB's total debt of 252.00M.
3.37T
Better than BB's total equity of 1.76B.
3.47T
Better than BB's total capital of 2.01B.
2.82%
Better than BB's debt weighting of 12.53%.
97.18%
Better than BB's equity weighting of 87.47%.
74.53B
Better than BB's ebiat of -133.86M.
61.62B
Better than BB's unlevered free cash flow of 48.09M.
4.00%
Better than BB's long-term growth rate of 2.00%.
3.24T
Better than BB's terminal value of -501.05M.
2.57T
Better than BB's enterprise value of -461.69M.
79.54B
Worse than BB's net debt of 77.00M.
2.49T
Better than BB's equity value of -538.69M.
334.02
Better than BB's equity value per share of -0.92.
View analysts' price targets and recommendations, and compare them with competitors.
$601.38
Higher upside than BB's upside of 2.56%.
Buy
Better than BB's analyst recommendation of Hold.
Analyze analyst forecasts for the company and compare them with competitors.
22.28B
No peer data available for comparison.
14.05B
No peer data available for comparison.
0.79
No peer data available for comparison.
8.95B
No peer data available for comparison.
10.50B
No peer data available for comparison.
4.91B
No peer data available for comparison.
